These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 24107853

  • 1. Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury.
    Nakayama Y, Ueda S, Yamagishi S, Obara N, Taguchi K, Ando R, Kaida Y, Iwatani R, Kaifu K, Yokoro M, Toyonaga M, Kusumoto T, Fukami K, Okuda S.
    Kidney Int; 2014 Mar; 85(3):570-8. PubMed ID: 24107853
    [Abstract] [Full Text] [Related]

  • 2. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B, Möller-Ehrlich K, Kress T, Kniepert J, Schwedhelm E, Böger RH, Wanner C, Sauvant C, Schneider R.
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [Abstract] [Full Text] [Related]

  • 3. Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile.
    Ferrigno A, Rizzo V, Bianchi A, Di Pasqua LG, Berardo C, Richelmi P, Vairetti M.
    Biomed Res Int; 2014 Aug; 2014():627434. PubMed ID: 25243167
    [Abstract] [Full Text] [Related]

  • 4. Specific Lowering of Asymmetric Dimethylarginine by Pharmacological Dimethylarginine Dimethylaminohydrolase Improves Endothelial Function, Reduces Blood Pressure and Ischemia-Reperfusion Injury.
    Lee Y, Mehrotra P, Basile D, Ullah M, Singh A, Skill N, Younes ST, Sasser J, Shekhar A, Singh J.
    J Pharmacol Exp Ther; 2021 Feb; 376(2):181-189. PubMed ID: 33214214
    [Abstract] [Full Text] [Related]

  • 5. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M, Merwid-Ląd A, Chlebda-Sieragowska E, Szuba A, Pieśniewska M, Fereniec-Gołębiewska L, Kwiatkowska J, Szeląg A, Sozański T.
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [Abstract] [Full Text] [Related]

  • 6. Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury.
    Stühlinger MC, Conci E, Haubner BJ, Stocker EM, Schwaighofer J, Cooke JP, Tsao PS, Pachinger O, Metzler B.
    Cardiovasc Res; 2007 Jul 15; 75(2):417-25. PubMed ID: 17559823
    [Abstract] [Full Text] [Related]

  • 7. Effect of ischemia-reperfusion on renal expression and activity of N(G)-N(G)-dimethylarginine dimethylaminohydrolases.
    Li Volti G, Sorrenti V, Acquaviva R, Murabito P, Gullo A, Barcellona ML, Galvano F, Rodella L, Rezzani R, Vanella L, Tringali G, Caruso M, Gazzolo D, Di Giacomo C.
    Anesthesiology; 2008 Dec 15; 109(6):1054-62. PubMed ID: 19034102
    [Abstract] [Full Text] [Related]

  • 8. DDAH-2 alleviates contrast medium iopromide-induced acute kidney injury through nitric oxide synthase.
    Lin HH, Lee TS, Lin SJ, Yeh YC, Lu TM, Hsu CP.
    Clin Sci (Lond); 2019 Dec 12; 133(23):2361-2378. PubMed ID: 31763675
    [Abstract] [Full Text] [Related]

  • 9. Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy.
    Wetzel MD, Gao T, Stanley K, Cooper TK, Morris SM, Awad AS.
    Am J Physiol Renal Physiol; 2020 Feb 01; 318(2):F509-F517. PubMed ID: 31904280
    [Abstract] [Full Text] [Related]

  • 10. Influence of ezetimibe on ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M, Merwid-Ląd A, Sozański T, Ewa Chlebda-Sieragowska E, Szuba A, Dzięgiel P, Pieśniewska M, Fereniec-Gołębiewska L, Kwiatkowska J, Gomułkiewicz A, Cwynar-Zając Ł, Brykner R, Szeląg A.
    Pharmacol Rep; 2013 Feb 01; 65(1):122-33. PubMed ID: 23563030
    [Abstract] [Full Text] [Related]

  • 11. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
    Matsuguma K, Ueda S, Yamagishi S, Matsumoto Y, Kaneyuki U, Shibata R, Fujimura T, Matsuoka H, Kimoto M, Kato S, Imaizumi T, Okuda S.
    J Am Soc Nephrol; 2006 Aug 01; 17(8):2176-83. PubMed ID: 16807406
    [Abstract] [Full Text] [Related]

  • 12. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity.
    Jiang JL, Zhang XH, Li NS, Rang WQ, Feng-Ye, Hu CP, Li YJ, Deng HW.
    Cardiovasc Drugs Ther; 2006 Aug 01; 20(4):281-94. PubMed ID: 16897158
    [Abstract] [Full Text] [Related]

  • 13. Asymmetric dimethylarginine, endothelial dysfunction and renal disease.
    Aldámiz-Echevarría L, Andrade F.
    Int J Mol Sci; 2012 Aug 01; 13(9):11288-11311. PubMed ID: 23109853
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine.
    Sharma S, Smith A, Kumar S, Aggarwal S, Rehmani I, Snead C, Harmon C, Fineman J, Fulton D, Catravas JD, Black SM.
    Vascul Pharmacol; 2010 Aug 01; 52(5-6):182-90. PubMed ID: 19962451
    [Abstract] [Full Text] [Related]

  • 15. Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness.
    Davids M, Richir MC, Visser M, Ellger B, van den Berghe G, van Leeuwen PA, Teerlink T.
    Metabolism; 2012 Apr 01; 61(4):482-90. PubMed ID: 22000584
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
    Dayoub H, Rodionov RN, Lynch C, Cooke JP, Arning E, Bottiglieri T, Lentz SR, Faraci FM.
    Stroke; 2008 Jan 01; 39(1):180-4. PubMed ID: 18063827
    [Abstract] [Full Text] [Related]

  • 17. Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.
    Matsumoto Y, Ueda S, Yamagishi S, Matsuguma K, Shibata R, Fukami K, Matsuoka H, Imaizumi T, Okuda S.
    J Am Soc Nephrol; 2007 May 01; 18(5):1525-33. PubMed ID: 17409314
    [Abstract] [Full Text] [Related]

  • 18. The impact of sitagliptin, inhibitor of dipeptidyl peptidase-4 (DPP-4), on the ADMA-DDAH-NO pathway in ischemic and reperfused rat livers.
    Trocha M, Nowak B, Merwid-Ląd A, Szuba A, Dzięgiel P, Pieśniewska M, Gomułkiewicz A, Wiśniewski J, Piasecki T, Gziut M, Szeląg A, Sozański T.
    Adv Clin Exp Med; 2018 Nov 01; 27(11):1483-1490. PubMed ID: 30303311
    [Abstract] [Full Text] [Related]

  • 19. Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy.
    Shibata R, Ueda S, Yamagishi S, Kaida Y, Matsumoto Y, Fukami K, Hayashida A, Matsuoka H, Kato S, Kimoto M, Okuda S.
    Nephrol Dial Transplant; 2009 Apr 01; 24(4):1162-9. PubMed ID: 19015171
    [Abstract] [Full Text] [Related]

  • 20. Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia.
    Anderssohn M, Maass LM, Diemert A, Lüneburg N, Atzler D, Hecher K, Böger RH.
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr 01; 161(2):152-6. PubMed ID: 22285683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.